Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Aug 7;19(29):4808-17.
doi: 10.3748/wjg.v19.i29.4808.

FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis

Affiliations
Meta-Analysis

FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis

Zhen Wang et al. World J Gastroenterol. .

Abstract

Aim: To investigate the potential role of positron emission tomography (PET) in the diagnosis, staging and prognosis predicting of pancreatic carcinoma (PC).

Methods: A systematic review of relevant literatures in PubMed, Embase and Cochrane Library was performed. The sensitivity and specificity of diagnostic and staging studies, and HRs for prognosis predicting studies were pooled. The bivariate model was used for diagnostic studies and the random-effect model for prognostic studies. Heterogeneity between included studies was tested using χ(2) test, and subgroup analysis was performed to explain the heterogeneities. All of the calculations were performed using Stata version 11.0.

Results: A total of 39 studies were included. The pooled sensitivity of PET in diagnosing PC (30 studies, 1582 patients), evaluating N stating (4 studies, 101 patients) and liver metastasis (7 studies, 316 patients) were 0.91 (95%CI: 0.88-0.93), 0.64 (95%CI: 0.50-0.76), and 0.67 (95%CI: 0.52-0.79), respectively; and the corresponding specificity was 0.81 (95%CI: 0.75-0.85), 0.81 (95%CI: 0.25-0.85), and 0.96 (95%CI: 0.89-0.98), respectively. In prognosis analysis (6 studies, 198 patients), significant difference of overall survival was observed between high and low standardized uptake value groups (HR = 2.39, 95%CI: 1.57-3.63). Subgroup analysis showed that PET/CT was more sensitive than PET alone in evaluating liver metastasis of PC, 0.82 (95%CI: 0.48-0.98) and 0.67 (95%CI: 0.52-0.79), respectively.

Conclusion: PET can be used as a valuable diagnostic and predictive tool for PC, but its effect in the staging of PC remains indeterminate.

Keywords: Diagnosis; Meta-analysis; Pancreatic carcinoma; Positron emission tomography; Prognosis; Staging.

PubMed Disclaimer

Figures

Figure 1
Figure 1
QUORUM flow chart for studies.
Figure 2
Figure 2
Methodological quality graph. A: Diagnosis and staging studies; B: Prognosis studies. Authors’ judgments about each methodological quality item presented as percentages across all included studies.
Figure 3
Figure 3
Forrest plot for the prognosis of pancreatic carcinoma. 1Patients received operation; 2Patients did not receive operation.
Figure 4
Figure 4
Hierarchical summary receiver operating characteristic curve. A: For the diagnosis of pancreatic carcinoma; B: For N staging of pancreatic carcinoma; C: For liver metastasis of pancreatic carcinoma. HSROC: Hierarchical summary receiver operating characteristic.
Figure 5
Figure 5
Funnel plot based on the data of positron emission tomography/ computed tomography for the diagnosis of pancreatic carcinoma.

Similar articles

Cited by

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
    1. Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol. 2011;17:867–897. - PMC - PubMed
    1. Heinrich S, Goerres GW, Schäfer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, Hany TF, von Schulthess GK, Clavien PA. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg. 2005;242:235–243. - PMC - PubMed
    1. American Cancer Society. Pancreatic cancer. Available from: http://www.cancer.org.
    1. Katz MH, Savides TJ, Moossa AR, Bouvet M. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology. 2005;5:576–590. - PubMed

Publication types

Substances